# Desvenlafaxine Succinate (Pristiq Extended-Release)

Source: https://ourhealthnetwork.com/drugs/desvenlafaxine-succinate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Desvenlafaxine Succinate?

Desvenlafaxine Succinate (brand name: Pristiq Extended-Release) is a selective serotonin and norepinephrine reuptake inhibitor (snris). It is prescribed to treat major depressive disorder. Across the United States, 22,000 doctors prescribe Desvenlafaxine to approximately 32,000 Medicare patients.

## Brand names

Pristiq Extended-Release

## Indications

Desvenlafaxine Succinate is primarily prescribed for the treatment of major depressive disorder.

## Conditions treated

- [Major Depressive Disorder](https://ourhealthnetwork.com/conditions/major-depressive-disorder)

## Mechanism of action

The exact mechanism of the antidepressant action of desvenlafaxine is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake. Non-clinical studies have shown that desvenlafaxine is a potent and selective SNRI.

## Drug classification

- Established Pharmacologic Class: selective serotonin and norepinephrine reuptake inhibitors (SNRIs)
- Route of administration: ORAL

## Common side effects

anxiety, constipation, decreased appetite, dizziness, hyperhidrosis, insomnia, nausea, somnolence

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)